nogo receptor antagonist peptide promotes axonal regeneration 
myelin-derived axon outgrowth inhibitors nogo may account lack axonal regeneration central nervous system cns trauma adult mammals residue domain nogo nogo- expressed surface oligodendrocytes can inhibit axonal outgrowth axonal nogo receptor ngr monoclonal antibody recognizes nogo-a promotes corticospinal tract regeneration locomotor recovery- however undefined nature epitope nogo limited specificity nogo nonspecific anti-myelin effects prevented firm conclusion role nogo ngr identify competitive antagonists ngr derived amino-terminal peptide fragments nogo- nogo-- antagonist peptide nep1- blocks nogo cns myelin inhibition axonal outgrowth vitro demonstrating ngr mediates significant portion axonal outgrowth inhibition myelin intrathecal administration nep1 rats mid-thoracic spinal cord hemisection results significant axon growth corticospinal tract improves functional recovery thus nogo ngr central roles limiting axonal regeneration cns injury nep1 provides potential therapeutic agent 
